ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
Promotion
Recombinantタンパク質s ClearClear history
Recombinantタンパク質s CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Bcl-x

Bcl-x

概要

Name:Apoptosis regulator Bcl-X
Target Synonym:Bcl-2-like protein 1,Bcl2-L-1,BCL2L,Apoptosis regulator Bcl-X,BCL2L1,BCL2 Like 1,Protein Phosphatase 1, Regulatory Subunit 52,BCLX,BCL-XL/S,PPP1R52,Bcl-X,bcl-X Protein,Bcl-XL,Bcl-XS
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品> フィルター結果
製品仕様別：
製品カテゴリー別：
種類別：
タグ別：
コンジュゲート：
製造番号 種類 製品説明 構造 純度 特徴
BC1-H513a Human Human Bcl-x / BCL2L1 Protein, GST Tag
BC1-H513a-structure
BC1-H513a-sds
BC1-H5120 Human Human Bcl-x / BCL2L1 Protein, His Tag
BC1-H5120-structure
BC1-H5120-sds
ACRO Quality

Synonym Name

BCL2L1,Bcl-XL,Bcl2-L-1,BCL-XL/S,BCL2L,BCLX,BCLXL,BCLXS,Bcl-X,bcl-xS

Background

Bcl-2-like protein 1 (BCL2L1), is also known as Apoptosis regulator Bcl-X (Bcl-XL). BCL2L1 / Bcl-XL is a homodimer protein and belongs to the Bcl-2 family. BCL2L1 is expressed at high levels in cells that undergo a high rate of turnover, such as developing lymphocytes. BCL2L1 is a potent inhibitor of cell death. BCL2L1 Inhibits activation of caspases. BCL2L1 appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. BCL2L1 / Bcl-XL also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Gossypol acetic acid/Potassium Chloride/Vitamin B1/Vitamin B6 Approved Mainland China Uterine Hemorrhage; Uterine Neoplasms; Endometriosis Xi'An Beifang Medicine Co Ltd 1988-01-01 Endometriosis; Uterine Hemorrhage; Uterine Neoplasms Details
R-(-)-gossypol acetic acid AT-101; BL-193; TW-37; NSC-726190 Approved University Of Michigan, Jiangsu Yasheng Pharmaceutical Development Co Ltd, National Institutes Of Health Mainland China Contraception; Genital Diseases, Female Shanxi Panlong Pharmaceutical Group Limited By Share Ltd 2002-01-01 Esophageal Neoplasms; Contraception; Genital Diseases, Female; Glioblastoma; Lymphoma, Large B-Cell, Diffuse; Small Cell Lung Carcinoma; Adrenocortical Carcinoma; Prostatic Neoplasms; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Brain Neoplasms; Gliosarcoma; Leukemia, Lymphocytic, Chronic, B-Cell Details
Gossypol acetic acid/Potassium Chloride/Vitamin B1/Vitamin B6 Approved Mainland China Uterine Hemorrhage; Uterine Neoplasms; Endometriosis Xi'An Beifang Medicine Co Ltd 1988-01-01 Endometriosis; Uterine Hemorrhage; Uterine Neoplasms Details
R-(-)-gossypol acetic acid AT-101; BL-193; TW-37; NSC-726190 Approved University Of Michigan, Jiangsu Yasheng Pharmaceutical Development Co Ltd, National Institutes Of Health Mainland China Contraception; Genital Diseases, Female Shanxi Panlong Pharmaceutical Group Limited By Share Ltd 2002-01-01 Esophageal Neoplasms; Contraception; Genital Diseases, Female; Glioblastoma; Lymphoma, Large B-Cell, Diffuse; Small Cell Lung Carcinoma; Adrenocortical Carcinoma; Prostatic Neoplasms; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Brain Neoplasms; Gliosarcoma; Leukemia, Lymphocytic, Chronic, B-Cell Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Pelcitoclax BM-1252; APG-1252 Phase 2 Clinical Jiangsu Yasheng Pharmaceutical Development Co Ltd Solid tumours; Ovarian Neoplasms; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lymphoma, Extranodal NK-T-Cell; Primary Myelofibrosis; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid Details
TGRX-814 TGRX-814 Phase 2 Clinical Hematologic Neoplasms; Leukemia; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma Details
LP-118 LP-118 Phase 2 Clinical Guangzhou Lupeng Pharmaceutical Co Ltd, Newave Pharmaceutical Inc Lymphoma, B-Cell; Solid tumours; Leukemia; Bone Marrow Neoplasms; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Richter's Syndrome; Primary Myelofibrosis; Leukemia, Prolymphocytic, T-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell Details
UBX-1325 UBX-1325 Phase 2 Clinical Unity Biotechnology Inc, Ascentage Pharma Group International Macular Edema; Diabetic macular oedema; Macular Degeneration Details
Mirzotamab clezutoclax ABBV-155 Phase 1 Clinical Abbvie Inc Solid tumours Details
DT-2216 DT-2216 Phase 1 Clinical University Of Florida, Dialectic Therapeutics Inc Hematologic Neoplasms; Solid tumours Details
ABBV-637 ABBV-637 Phase 1 Clinical Abbvie Inc Solid tumours; Carcinoma, Non-Small-Cell Lung Details
Pelcitoclax BM-1252; APG-1252 Phase 2 Clinical Jiangsu Yasheng Pharmaceutical Development Co Ltd Solid tumours; Ovarian Neoplasms; Small Cell Lung Carcinoma; Neuroendocrine Tumors; Lymphoma, Extranodal NK-T-Cell; Primary Myelofibrosis; Peritoneal Neoplasms; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid Details
TGRX-814 TGRX-814 Phase 2 Clinical Hematologic Neoplasms; Leukemia; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma Details
LP-118 LP-118 Phase 2 Clinical Guangzhou Lupeng Pharmaceutical Co Ltd, Newave Pharmaceutical Inc Lymphoma, B-Cell; Solid tumours; Leukemia; Bone Marrow Neoplasms; Neoplasms; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Richter's Syndrome; Primary Myelofibrosis; Leukemia, Prolymphocytic, T-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell Details
UBX-1325 UBX-1325 Phase 2 Clinical Unity Biotechnology Inc, Ascentage Pharma Group International Macular Edema; Diabetic macular oedema; Macular Degeneration Details
Mirzotamab clezutoclax ABBV-155 Phase 1 Clinical Abbvie Inc Solid tumours Details
DT-2216 DT-2216 Phase 1 Clinical University Of Florida, Dialectic Therapeutics Inc Hematologic Neoplasms; Solid tumours Details
ABBV-637 ABBV-637 Phase 1 Clinical Abbvie Inc Solid tumours; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totopphone
Call us
お問い合わせ
グローバル：+1 800-810-0816(Toll Free)
日本：+(0)81-50-547-99099
Email
メールアドレス
order.jp@acrobiosystems.com
Fax
ファックス
+1 888-377-6111
Address
株式会社アクロバイオシステムズ
〒157-0066
東京都世田谷区成城1丁目26番9-101号

アクロバイオシステムズの公式アカウント

linkedin twitter facebook youtube

お問い合わせ（半角英文字で入力してください）

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap